SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-016824
Filing Date
2018-06-15
Accepted
2018-06-15 17:52:39
Documents
2
Period of Report
2018-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4171
2 EX-24 DOCUMENT attachment1.htm EX-24 5022
  Complete submission text file 0000899243-18-016824.txt   10606
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Fuchs Charles S. (Reporting) CIK: 0001719576 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 18903251